Related Experiment Videos
[Hypertension and chronic renal insufficiency]
1Klinische Abteilung für Nephrologie, Universitätsklinik für Innere Medizin, Leopold-Franzens-Universität, Anichstrasse 35, A-6020 Innsbruck. alexander.rosenkranz@uibk.ac.at
Acta Medica Austriaca
|July 28, 2001
Summary
Rising rates of kidney failure can be slowed by managing blood pressure. Antihypertensive drugs, especially angiotensin-converting enzyme inhibitors, protect kidneys in hypertensive patients with chronic renal failure.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Context:
- Increasing incidence of end-stage renal disease.
- Hypertension as a major risk factor for chronic kidney disease progression.
Purpose:
- To review the pathogenesis of renal insufficiency in hypertensive patients.
- To discuss current treatment strategies and the role of renoprotective drugs.
- To highlight the benefits of angiotensin-converting enzyme inhibitors.
Summary:
- Antihypertensive therapy, regardless of drug class, slows renal insufficiency progression.
- Angiotensin-converting enzyme inhibitors offer renoprotection beyond blood pressure reduction.
- Management of systolic and diastolic blood pressure is crucial.
Impact:
- Provides guidance on managing hypertensive patients with chronic renal failure.
- Emphasizes the importance of renoprotective agents in kidney disease treatment.
- Contributes to understanding the link between hypertension and kidney health.